NEW ORLEANS, LA—Dabigatran 150mg was superior to warfarin and dabigatran 110mg was noninferior to warfarin for preventing stroke in patients with atrial fibrillation (AF) regardless of CHA2DS2-VASc ...

Please provide your email address to receive an email when new articles are posted on . Katia Orvin, MD, of the cardiology department of Rabin Medical Center at Tel-Aviv University in Israel, and ...

Please provide your email address to receive an email when new articles are posted on . The strongest predictors of incident AF with a HR of 1.2 or greater were hypertension, older age, CAD, HF, ...

Physicians and atrial fibrillation patients must weigh the risks and benefits of using blood thinners to prevent stroke, bleeding, and death -- but current guidelines don't do enough to discern a ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its diagnosis and management are crucial tasks for emergency physicians. An important aspect of treating patients with AF is ...

Female sex has a strong relationship with stroke risk in patients with nonvalvular A-fib, a new analysis affirms, but the disparity between women and men varies according to the presence of other risk ...

A recent British study published in European Heart Journal has reignited discussions on the role of sex as a determinant in prescribing anticoagulants, particularly for patients under the age of 65.

Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011; ...

Biomarkers improve CHA2DS2-VASc model fit and predictive ability, with NTproBNP and GDF-15 yielding the best fit. (HealthDay News) — Biomarkers of ischemic stroke risk are positively associated with ...

Although patients with A-fib and those with atrial flutter (AFL) are generally managed by clinicians in much the same way for stroke prevention, new data suggest that a common risk score used for both ...

BOSTON -- In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for whom the ...